Completed OBSERVATIONAL NCT01327378

The Incretin Effect in Patients With Kidney Impairment (UREMINC)

The Incretin Effect in Non-diabetic Patients With Severe Renal Impairment Depending on Chronic Dialysis Treatment

Sponsor: Rigshospitalet, Denmark

Updated 10 times since 2017 Last updated: Mar 31, 2011 Started: Mar 31, 2009 Primary completion: Oct 31, 2010 Completion: Oct 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Renal Insufficiency, Chronic, this trial is completed. The trial is conducted by Rigshospitalet, Denmark and has accumulated 10 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rigshospitalet, Denmark
University Hospital, Gentofte, Copenhagen
University of Copenhagen

Data source: University Hospital, Gentofte, Copenhagen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen Ø, Denmark